{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:54:15Z","timestamp":1791935655383,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1563,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41374-018-0044-5","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T16:51:53Z","timestamp":1521046313000},"page":"1291-1299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Proteomic signature of circulating extracellular vesicles in dilated cardiomyopathy"],"prefix":"10.1016","volume":"98","author":[{"given":"Santiago","family":"Roura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"G\u00e1mez-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Lup\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"G\u00e1lvez-Mont\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc E.","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Bayes-Genis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-018-0044-5_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/415227a","article-title":"The failing heart","volume":"415","author":"Towbin","year":"2002","journal-title":"Nature"},{"key":"10.1038\/s41374-018-0044-5_bib2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/s41374-018-0044-5_bib3","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2010.11.061","article-title":"Arrhythmias and dilated cardiomyopathy common pathogenetic pathways?","volume":"57","author":"Towbin","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/s41374-018-0044-5_bib4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ejheart.2007.07.008","article-title":"Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation","volume":"9","author":"Roura","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/s41374-018-0044-5_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrcardio.2009.130","article-title":"Vascular dysfunction in idiopathic dilated cardiomyopathy","volume":"6","author":"Roura","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1038\/s41374-018-0044-5_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group.","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/s41374-018-0044-5_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12265-015-9671-z","article-title":"Circulating endothelial progenitor cells: potential biomarkers for idiopathic dilated cardiomyopathy","volume":"9","author":"Roura","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1038\/s41374-018-0044-5_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2310\/JIM.0b013e3182946b69","article-title":"Natriuretic peptides as biomarkers in heart failure","volume":"61","author":"Januzzi","year":"2013","journal-title":"J Investig Med"},{"key":"10.1038\/s41374-018-0044-5_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12265-013-9462-3","article-title":"New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy","volume":"6","author":"Gopal","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1038\/s41374-018-0044-5_bib10","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell vesicles [Internet]"},{"key":"10.1038\/s41374-018-0044-5_bib11","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-15-0201","article-title":"Microvesicles and exosomes: new players in metabolic and cardiovascular disease","volume":"228","author":"Lawson","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1038\/s41374-018-0044-5_bib12","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/jcmm.13211","article-title":"Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy","volume":"21","author":"Roura","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1038\/s41374-018-0044-5_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.303.6803.610","article-title":"Informed consent: study of quality of information given to participants in a clinical trial","volume":"303","author":"Lyn\u00f6e","year":"1991","journal-title":"BMJ"},{"key":"10.1038\/s41374-018-0044-5_bib14","first-page":"1","article-title":"Collection, storage, and preparation of human blood cells","volume":"73","author":"Dagur","year":"2015","journal-title":"Curr Protoc Cytom"},{"key":"10.1038\/s41374-018-0044-5_bib15","doi-asserted-by":"crossref","first-page":"23430","DOI":"10.3402\/jev.v3.23430","article-title":"Single-step isolation of extracellular vesicles by size-exclusion chromatography","volume":"3","author":"Boing","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"10.1038\/s41374-018-0044-5_bib16","first-page":"22","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"3","author":"Thery","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"key":"10.1038\/s41374-018-0044-5_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11249-2","article-title":"A bead-assisted flow cytometry method for the semi-quantitative analysis of extracellular vesicles","volume":"7","author":"Su\u00e1rez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1038\/s41374-018-0044-5_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"10.1038\/s41374-018-0044-5_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"EV-TRACK Consortium","year":"2017","journal-title":"Nat Methods"},{"key":"10.1038\/s41374-018-0044-5_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcvm.2016.00037","article-title":"Multi-biomarker profiling and recurrent hospitalizations in heart failure","volume":"3","author":"Bayes-Genis","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"10.1038\/s41374-018-0044-5_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fimmu.2015.00381","article-title":"Editorial: novel clinical applications of extracellular vesicles","volume":"6","author":"S\u00e1enz-Cuesta","year":"2015","journal-title":"Front Immunol"},{"key":"10.1038\/s41374-018-0044-5_bib22","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1038\/s41374-018-0044-5_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep33641","article-title":"Size-exclusion chromatography-based isolation minimally alters extracellular vesicles' characteristics compared to precipitating agents","volume":"6","author":"G\u00e1mez-Valero","year":"2016","journal-title":"Sci Rep"},{"key":"10.1038\/s41374-018-0044-5_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1373\/clinchem.2010.145342","article-title":"Fibrinogen assays for cardiovascular risk assessment","volume":"56","author":"Lowe","year":"2010","journal-title":"Clin Chem"},{"key":"10.1038\/s41374-018-0044-5_bib25","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant metaanalysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"10.1038\/s41374-018-0044-5_bib26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/s41374-018-0044-5_bib27","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/ATVBAHA.115.306284","article-title":"Association of plasma gamma' fibrinogen with incident cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"35","author":"Appiah","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/s41374-018-0044-5_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","article-title":"Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction","volume":"34","author":"Becatti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/s41374-018-0044-5_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MAJ.0b013e3181cf048a","article-title":"Dilated cardiomyopathy and role of antithrombotic therapy","volume":"339","author":"Abdo","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1038\/s41374-018-0044-5_bib30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"10.1038\/s41374-018-0044-5_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cardfail.2009.05.010","volume":"15","author":"Comin-Colet","year":"2009","journal-title":"J Card Fail"},{"key":"10.1038\/s41374-018-0044-5_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"10.1038\/s41374-018-0044-5_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1038\/s41374-018-0044-5_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","article-title":"Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches","volume":"8","author":"Van Veldhuisen","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1038\/s41374-018-0044-5_bib35","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/cr010170+","article-title":"Serpin structure, mechanism, and function","volume":"102","author":"Gettins","year":"2002","journal-title":"Chem Rev"},{"key":"10.1038\/s41374-018-0044-5_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jprot.2016.07.020","article-title":"Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy","volume":"148","author":"Izquierdo","year":"2016","journal-title":"J Proteom"},{"key":"10.1038\/s41374-018-0044-5_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","article-title":"Clusterin","volume":"34","author":"Jones","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/s41374-018-0044-5_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0065-230X(09)04006-8","article-title":"Chapter 6: the chaperone action of clusterin and its putative role in quality control of extracellular protein folding","volume":"104","author":"Wyatt","year":"2009","journal-title":"Adv Cancer Res"},{"key":"10.1038\/s41374-018-0044-5_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11154-013-9275-3","article-title":"The physiological roles of apolipoprotein J\/clusterin in metabolic and cardiovascular diseases","volume":"15","author":"Park","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1038\/s41374-018-0044-5_bib40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0531-5565(02)00139-0","article-title":"Serum levels of the senescence biomarker clusterin\/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction","volume":"37","author":"Trougakos","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1038\/s41374-018-0044-5_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacl.2016.11.009","article-title":"Clusterin\/apolipoprotein J is independently associated with survival in patients with chronic heart failure","volume":"11","author":"Koller","year":"2017","journal-title":"J Clin Lipidol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0044-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372201090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372201090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:34:48Z","timestamp":1758396888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372201090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S002368372201090X"],"URL":"https:\/\/doi.org\/10.1038\/s41374-018-0044-5","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic signature of circulating extracellular vesicles in dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-018-0044-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}